| Dr J Hamilton Easter Jr, MD | |
|
720 S Queen St, Dover, DE 19904-3567 | |
| (302) 735-8705 | |
| (302) 735-8703 |
| Full Name | Dr J Hamilton Easter Jr |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 720 S Queen St, Dover, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104820620 | NPI | - | NPPES |
| 232589680 | Other | DE | FEP |
| 21873 | Other | DE | MAMSI |
| 232589680 | Other | DE | BLUE CROSS |
| 29204 | Other | DE | COVENTRY HEALTH CARE |
| 0000144404 | Medicaid | DE | |
| 232589680 | Other | DE | PROVIDER ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | C10002873 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr J Hamilton Easter Jr, MD 720 S Queen St, Dover, DE 19904-3567 Ph: (302) 735-8705 | Dr J Hamilton Easter Jr, MD 720 S Queen St, Dover, DE 19904-3567 Ph: (302) 735-8705 |
News Archive
Virginia Commonwealth University School of Medicine researchers have made an important advancement toward developing a vaccine against the debilitating and potentially deadly tick-transmitted disease, human granulocytic anaplasmosis (HGA).
Cardioxyl Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing novel therapeutic agents for the treatment of cardiovascular disease, today announced that it has achieved positive safety and tolerability results in the first clinical study of its lead drug candidate, CXL-1020, for the treatment of patients with acute decompensated heart failure. Each year in the United States, more than one million patients are hospitalized with acute heart failure.
A furore has erupted in Britain over a decision by the National Institute for Clinical Excellence (NICE), not to recommend the use of an Alzheimer's drug for newly diagnosed patients.
Cell Therapeutics, Inc. today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone.
› Verified 1 days ago
John Robert Burger, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 655 S Bay Rd Ste 1f, Dover, DE 19901 Phone: 302-730-4366 Fax: 302-730-0231 | |
Jonathan L Kates, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 540 S Governors Ave, Suite 201, Dover, DE 19904 Phone: 302-730-4366 Fax: 302-730-0231 | |
Stephen L Malone, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 260 Beiser Blvd, Suite 101, Dover, DE 19904 Phone: 302-734-9700 Fax: 302-734-9702 | |
Steven E Tooze, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 285 Beiser Blvd Ste 201, Dover, DE 19904 Phone: 302-731-2888 Fax: 302-731-7049 | |
Dr. Andrew Joseph Gambone, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 655 S Bay Rd Ste 1f, Dover, DE 19901 Phone: 302-730-4366 Fax: 302-730-0231 | |
Lawrence Piccioni, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 260 Beiser Blvd, Suite 101, Dover, DE 19904 Phone: 302-730-8060 Fax: 302-730-8063 |